1. Exploring the prominent performance of CX-4945 derivatives as protein kinase CK2 inhibitors by a combined computational study
   Xuwen Wang et al, 2014, Mol. BioSyst. CrossRef
2. Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7
   Abdelhamid Nacereddine et al, 2018, Pharmaceuticals CrossRef
3. CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
   Melissa Chua et al, 2017, Pharmaceuticals CrossRef
4. Development of a high-throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction
   Jennifer Hochscherf et al, 2015, Analytical Biochemistry CrossRef
5. Drug design targeting active posttranslational modification protein isoforms
   Fanwang Meng et al, 2021, Medicinal Research Reviews CrossRef
6. Targeting the Wnt/β-catenin signaling pathway in cancer
   Ya Zhang et al, 2020, Journal of Hematology & Oncology CrossRef
7. Identification of compounds inhibiting prion replication and toxicity by removing PrPC from the cell surface
   Silvia Biggi et al, 2020, Journal of Neurochemistry CrossRef
8. Small molecule inhibitors of IκB kinase β: A chip-based screening and molecular docking simulation
   Yong Wan Cho et al, 2020, Bioorganic & Medicinal Chemistry CrossRef
9. Casein kinase (CK) inhibitors
   Xin Zhai, 2024, Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy CrossRef
10. Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines
    Ke Li et al, 2019, International Journal of Molecular Medicine CrossRef
11. Synthesis, biological properties and structural study of new halogenated azolo[4,5-b]pyridines as inhibitors of CK2 kinase
    K. Chojnacki et al, 2021, Bioorganic Chemistry CrossRef
12. Molecular docking of brazilin and its analogs to barrier‐to‐autointegration factor 1 (BAF1)
    Maria de Nazaré Correia Soeiro et al, 2022, Annals of the New York Academy of Sciences CrossRef
13. Discovery of an adjuvant that resensitizes polymyxin B-resistant bacteria
    Michael Mahdavi et al, 2024, Bioorganic & Medicinal Chemistry CrossRef
14. High-Order Perturbation Theory Models of Drug-Target Interactomes for Proteins Expressed on Networks of Hippocampus Brain Region of Alzheimer Disease Patients
    J Romero-Durán et al, 2016, Biopolymers for Medical Applications CrossRef
15. Casein kinase: the triple meaning of a misnomer
    Andrea Venerando et al, 2014, Biochemical Journal CrossRef
16. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways
    Ling‑Qi Meng et al, 2017, Molecular Medicine Reports CrossRef
17. Novel regulators of PrPC expression as potential therapeutic targets in prion diseases
    Arianna Colini Baldeschi et al, 2020, Expert Opinion on Therapeutic Targets CrossRef